keyword
MENU ▼
Read by QxMD icon Read
search

ELN

keyword
https://www.readbyqxmd.com/read/30113440/vascular-endothelial-growth-factor-enhances-proliferation-of-human-tenocytes-and-promotes-tenogenic-gene-expression
#1
Armin Kraus, Daniel Sattler, Markus Wehland, Ronald Luetzenberg, Nauras Abuagela, Manfred Infanger
BACKGROUND: In obtaining human tenocytes in a sufficient number for tendon tissue engineering, low proliferation rate and phentoype loss during passaging is a problem. It was our aim to evalute the influence of VEGF on human tenocyte growth and gene expression. MATERIALS AND METHODS: Human tenocytes were obtained from surgical specimens and exposed to human VEGF in various concentrations (5ng/ml, 10ng/ml, 20ng/ml) for 5 days. Cell proliferation was counted and expression of tendon-related genes (Col1, Col3, TSC, SCX and ELN) was analyzed...
August 11, 2018: Plastic and Reconstructive Surgery
https://www.readbyqxmd.com/read/30105533/chemotion-eln-part-2-adaption-of-an-embedded-ketcher-editor-to-advanced-research-applications
#2
Serhii Kotov, Pierre Tremouilhac, Nicole Jung, Stefan Bräse
The Ketcher editor, available as an Open Source software package for drawing chemical structures, has been expanded to include several features that allow storage, management and application of templates, as well as the use of symbols for a planning and processing of solid phase synthesis. In addition, tools for the drawing of coordinative bonds to represent e.g. organometallic compounds were added. The editor has been implemented into an Electronic Lab Notebook (ELN) application which enables the use of the Ketcher editor for advanced operations in chemistry research...
August 13, 2018: Journal of Cheminformatics
https://www.readbyqxmd.com/read/30088984/role-of-mir-29-in-mediating-offspring-lung-phenotype-in-a-rodent-model-of-intrauterine-growth-restriction
#3
Tsai-Der Chuang, Reiko Sakurai, Ming Gong, Omid Khorram, Virender K Rehan
Considerable epidemiological and experimental evidence supports the concept that the adult chronic lung disease (CLD), at least in part, is due to aberrations in early lung development in response to an abnormal intrauterine environment; however, the underlying molecular mechanisms remain unknown. We used a well-established rat model of maternal undernutrition (MUN) during pregnancy that results in offspring intrauterine growth restriction (IUGR) and adult CLD to test the hypothesis that excess maternal glucocorticoids in response to MUN programs offspring lung development to a CLD phenotype by altering miRNA (miR)-29 expression, which is a key miR in regulating extracellular matrix (ECM) deposition during development and injury-repair...
August 8, 2018: American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
https://www.readbyqxmd.com/read/30085172/european-guidelines-for-primary-antifungal-prophylaxis-in-adult-haematology-patients-summary-of-the-updated-recommendations-from-the-european-conference-on-infections-in-leukaemia
#4
Johan A Maertens, Corrado Girmenia, Roger J Brüggemann, Rafael F Duarte, Christopher C Kibbler, Per Ljungman, Zdenek Racil, Patricia Ribaud, Monica A Slavin, Oliver A Cornely, J Peter Donnelly, Catherine Cordonnier
The European Conference on Infections in Leukaemia (ECIL) updated its guidelines on antifungal prophylaxis for adults using the grading system of IDSA. The guidelines were extended to provide recommendations for other haematological diseases besides AML and recipients of an allogeneic haematopoietic stem cell transplantation (HSCT). Posaconazole remains the drug of choice when the incidence of invasive mould diseases exceeds 8%. For patients undergoing remission-induction chemotherapy for AML and myelodysplastic syndrome (MDS), fluconazole can still offer an alternative provided it forms part of an integrated care strategy that includes screening with biomarkers and imaging...
August 1, 2018: Journal of Antimicrobial Chemotherapy
https://www.readbyqxmd.com/read/30058714/comparable-outcomes-of-haploidentical-10-10-and-9-10-unrelated-donor-transplantation-in-adverse-karyotype-aml-in-first-complete-remission
#5
Francesca Lorentino, Myriam Labopin, Massimo Bernardi, Fabio Ciceri, Gerard Socié, Jan J Cornelissen, Jordi Esteve, Annalisa Ruggeri, Liisa Volin, Ibrahim Yacoub-Agha, Charles Craddock, Jacob Passweg, Didier Blaise, Tobias Gedde-Dahl, Monica Poiani, Nathalie Fegueux, Mohamad Mohty, Arnon Nagler
Allogeneic hematopoietic stem cell transplantation (HSCT) is the most powerful therapy preventing relapse in patients with adverse cytogenetics acute myeloid leukemia (AML) in first complete remission (CR1). In the absence of a matched related donor, potential alternatives include 10/10, 9/10 HLA-matched unrelated (UD) or haploidentical (Haplo) donors. We analyzed clinical outcomes of patients undergoing T-cell repleted Haplo (n=74), 10/10 UD (n=433) and 9/10 UD HSCT (n=123) from 2007 to 2015, reported to the EBMT Registry...
July 30, 2018: American Journal of Hematology
https://www.readbyqxmd.com/read/30042881/achilles-and-tail-tendons-of-perlecan-exon-3-null-heparan-sulphate-deficient-mice-display-surprising-improvement-in-tendon-tensile-properties-and-altered-collagen-fibril-organisation-compared-to-c57bl-6-wild-type-mice
#6
Cindy C Shu, Margaret M Smith, Richard C Appleyard, Christopher B Little, James Melrose
The aim of this study was to determine the role of the perlecan (Hspg2) heparan sulphate (HS) side chains on cell and matrix homeostasis in tail and Achilles tendons in 3 and 12 week old Hspg2 exon 3 null HS deficient ( Hspg2 Δ3 - ∕Δ3 - ) and C57 BL/6 Wild Type (WT) mice. Perlecan has important cell regulatory and matrix organizational properties through HS mediated interactions with a range of growth factors and morphogens and with structural extracellular matrix glycoproteins which define tissue function and allow the resident cells to regulate tissue homeostasis...
2018: PeerJ
https://www.readbyqxmd.com/read/30009341/molecular-remission-at-the-end-of-treatment-is-a-necessary-goal-for-a-good-outcome-in-eln-favorable-risk-acute-myeloid-leukemia-a-real-life-analysis-on-201-patients-by-the-rete-ematologica-lombarda-network
#7
Patrizia Zappasodi, Laura Marbello, Erika Borlenghi, Monica Fumagalli, Massimo Bernardi, Nicola Fracchiolla, Valentina Mancini, Matteo Da Vià, Emanuele Ravano, Elisa Cerqui, Virginia Valeria Ferretti, Barbara Rocca, Celeste Calvello, Mario Cazzola, Carlo Castagnola, Giuseppe Rossi
Favorable acute myeloid leukemia (AML) patients (pts.) demonstrate a relatively good outcome with standard induction; thus, pts. are generally not addressed to allogeneic transplant in first remission. However, it is not clear if also in a real-life setting, the outcome is homogeneous in the different favorable molecular groups and which are the parameters significantly associated to an increased relapse risk, useful to suggest the need of an intensified approach. In order to clarify this point, we collected clinical data on consecutive unselected AML pts...
July 15, 2018: Annals of Hematology
https://www.readbyqxmd.com/read/29983511/identification-of-prognostic-and-susceptibility-markers-in-chronic-myeloid-leukemia-using-next-generation-sequencing
#8
Yogender Shokeen, Neeta Raj Sharma, Abhishek Vats, Vibha Taneja, Sachin Minhas, Mayank Jauhri, Satish Sankaran, Shyam Aggarwal
Background: Incidence of Chronic Myeloid Leukemia (CML) is continuously increasing and expected to reach 100,000 patients every year by 2030. Though the discovery of Imatinib Mesylate (IM) has brought a paradigm shift in CML treatment, 20% patients show resistance to this tyrosine kinase inhibiter (TKI). Therefore, it is important to identify markers, which can predict the occurrence and prognosis of CML. Clinical Exome Sequencing, panel of more than 4800 genes, was performed in CML patients to identify prognostic and susceptibility markers in CML...
March 2018: Ethiopian Journal of Health Sciences
https://www.readbyqxmd.com/read/29978812/cytogenetic-profiles-of-472-indian-children-with-acute-myeloid-leukemia
#9
Anudishi Tyagi, Raja Pramanik, Shilpi Chaudhary, Anita Chopra, Sameer Bakhshi
OBJECTIVE: To analyze the cytogenetic abnormalities of a large cohort of consecutive pediatric Acute Myeloid Leukemia (AML) patients, treated on a uniform protocol. DESIGN: Review of case records. SETTING: Pediatric Cancer Center of tertiary care hospital between June 2003 and June 2016. PARTICIPANTS: 617 consecutive de novo pediatric AML patients were screened and 472 patients were found eligible. Eligibility criteria included non M3 patients, successful cytogenetic profile and availability of complete records...
June 15, 2018: Indian Pediatrics
https://www.readbyqxmd.com/read/29925908/front-line-imatinib-treatment-in-children-and-adolescents-with-chronic-myeloid-leukemia-results-from-a-phase-iii-trial
#10
Meinolf Suttorp, Philipp Schulze, Ingmar Glauche, Gudrun Göhring, Nils von Neuhoff, Markus Metzler, Petr Sedlacek, Eveline S J M de Bont, Adriana Balduzzi, Birgitte Lausen, Olga Aleinikova, Sabina Sufliarska, Günter Henze, Gabriele Strauss, Angelika Eggert, Bernhard Kremens, Andreas H Groll, Frank Berthold, Christoph Klein, Ute Groß-Wieltsch, Karl Walter Sykora, Arndt Borkhardt, Andreas E Kulozik, Martin Schrappe, Christina Nowasz, Manuela Krumbholz, Josephine T Tauer, Alexander Claviez, Jochen Harbott, Hans H Kreipe, Brigitte Schlegelberger, Christian Thiede
A total of 156 patients (age range 1.3-18.0 years, median 13.2 years; 91 (58.3%) male) with newly diagnosed CML (N = 146 chronic phase (CML-CP), N = 3 accelerated phase (CML-AP), N = 7 blastic phase (CML-BP)) received imatinib up-front (300, 400, 500 mg/m2 , respectively) within a prospective phase III trial. Therapy response, progression-free survival, causes of treatment failure, and side effects were analyzed in 148 children and adolescents with complete data. Event-free survival rate by 18 months for patients in CML-CP (median follow-up time 25 months, range: 1-120) was 97% (95% CI, 94...
June 20, 2018: Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.K
https://www.readbyqxmd.com/read/29872168/nf1-mutations-are-recurrent-in-adult-acute-myeloid-leukemia-and-confer-poor-outcome
#11
Ann-Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, Alice Mims, Christopher J Walker, James S Blachly, Deedra Nicolet, Shelley Orwick, Sophia E Maharry, Andrew J Carroll, Bayard L Powell, Jonathan E Kolitz, Eunice S Wang, Richard M Stone, Albert de la Chapelle, John C Byrd, Clara D Bloomfield
Targeted mutation assessment of 81 genes in 1021 adults with de novo acute myeloid leukemia (AML) identified recurrent mutations in the neurofibromin 1 (NF1) gene in 52 (5.1%) patients, including 36 (5.2%) younger and 16 (4.8%) older patients, which suggests NF1 belongs to the 20 most frequently mutated genes in adult AML. NF1 mutations were found throughout the gene, and comprised missense, frameshift, and nonsense mutations. One mutation hotspot, at amino acid threonine 676 (Thr676), was found in 27% of AML patients with NF1 mutations...
June 5, 2018: Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.K
https://www.readbyqxmd.com/read/29867527/the-reparative-abilities-of-menstrual-stem-cells-modulate-the-wound-matrix-signals-and-improve-cutaneous-regeneration
#12
Jimena Cuenca, Alice Le-Gatt, Valentina Castillo, Jose Belletti, Macarena Díaz, Mónica Kurte G, Paz L Gonzalez, Francisca Alcayaga-Miranda, Christina M A P Schuh, Fernando Ezquer, Marcelo Ezquer, Maroun Khoury
Considerable advances have been made toward understanding the cellular and molecular mechanism of wound healing, however, treatments for chronic wounds remain elusive. Emerging concepts utilizing mesenchymal stem cells (MSCs) from umbilical cord, adipose tissue and bone marrow have shown therapeutical advantages for wound healing. Based on this positive outcome, efforts to determine the optimal sources for MSCs are required in order to improve their migratory, angiogenic, immunomodulatory, and reparative abilities...
2018: Frontiers in Physiology
https://www.readbyqxmd.com/read/29845406/central-lymph-node-status-has-significant-prognostic-value-in-the-clinically-node-negative-tall-cell-variant-of-papillary-thyroid-cancer-regardless-of-t-staging-and-radioactive-iodine-administration-first-evidence-from-a-population-based-study
#13
Xiao Shi, Nai-Si Huang, Bo-Wen Lei, Ke-Han Song, Rong-Liang Shi, Wen-Jun Wei, Wei-Ping Hu, Fan Dong, Yu Wang, Yu-Long Wang, Qing-Hai Ji
BACKGROUND: The prognostic value of central lymph node (CLN) status in papillary thyroid cancer (PTC) remains controversial. This study aimed to provide the first evidence on this issue for the aggressive tall-cell variant (TCV) subtype. METHODS: The study identified TCV patients from the Surveillance, Epidemiology, and End Results database. The Kaplan-Meier method, log-rank test, and multivariate Cox regression models were used for analysis. RESULTS: Of the 744 patients included, 404 were recorded as N0, which were pathologically or only clinically confirmed...
August 2018: Annals of Surgical Oncology
https://www.readbyqxmd.com/read/29793046/validation-of-the-revised-pretransplant-assessment-of-mortality-score-in-patients-with-acute-myelogenous-leukemia-undergoing-allogeneic-hematopoietic-stem-cell-transplantation
#14
Jan M Middeke, Frederike Kollinger, Henning Baldauf, Friedrich Stölzel, Martin Wermke, Malte von Bonin, Katja Sockel, Cornelia S Link, Raphael Teipel, Christoph Röllig, Christian Thiede, Uwe Platzbecker, Gerhard Ehninger, Martin Bornhäuser, Johannes Schetelig
Despite recent advances, allogeneic hematopoietic stem cell transplantation (allo-HSCT) continues to be accompanied by a high rate of morbidity and mortality. Several scores have been developed to predict outcome after allo-HSCT. The recently revised Pretransplant Assessment of Mortality (PAM) score is based on patient age, donor type, disease risk, cytomegalovirus (CMV) serostatus of patient and donor, and forced expiratory volume in 1 second (FEV1 ). The aim of this study was to analyze the predictive power of the PAM score in an independent large cohort of patients with acute myelogenous leukemia (AML)...
May 21, 2018: Biology of Blood and Marrow Transplantation
https://www.readbyqxmd.com/read/29748891/exploration-of-the-exact-prognostic-significance-of-lymphatic-metastasis-in-jejunoileal-neuroendocrine-tumors
#15
Luohai Chen, Yunda Song, Yu Zhang, Minhu Chen, Jie Chen
BACKGROUND: How to evaluate the prognostic significance of lymphatic metastasis in patients with small bowel (jejunoileal) neuroendocrine tumors (SBNETs) is still not conclusive. METHODS: Data for patients with SBNETs, but without distant metastasis, were retrieved from the Surveillance, Epidemiology, and End Results database. Recursive partitioning analysis (RPA) was used for classification development by combining examined lymph nodes (ELNs) and lymph node ratio (LNR)...
July 2018: Annals of Surgical Oncology
https://www.readbyqxmd.com/read/29735299/discontinuation-of-tyrosine-kinase-inhibitor-therapy-in-chronic-myeloid-leukaemia-euro-ski-a-prespecified-interim-analysis-of-a-prospective-multicentre-non-randomised-trial
#16
Susanne Saussele, Johan Richter, Joelle Guilhot, Franz X Gruber, Henrik Hjorth-Hansen, Antonio Almeida, Jeroen J W M Janssen, Jiri Mayer, Perttu Koskenvesa, Panayiotis Panayiotidis, Ulla Olsson-Strömberg, Joaquin Martinez-Lopez, Philippe Rousselot, Hanne Vestergaard, Hans Ehrencrona, Veli Kairisto, Katerina Machová Poláková, Martin C Müller, Satu Mustjoki, Marc G Berger, Alice Fabarius, Wolf-Karsten Hofmann, Andreas Hochhaus, Markus Pfirrmann, Francois-Xavier Mahon
BACKGROUND: Tyrosine kinase inhibitors (TKIs) have improved the survival of patients with chronic myeloid leukaemia. Many patients have deep molecular responses, a prerequisite for TKI therapy discontinuation. We aimed to define precise conditions for stopping treatment. METHODS: In this prospective, non-randomised trial, we enrolled patients with chronic myeloid leukaemia at 61 European centres in 11 countries. Eligible patients had chronic-phase chronic myeloid leukaemia, had received any TKI for at least 3 years (without treatment failure according to European LeukemiaNet [ELN] recommendations), and had a confirmed deep molecular response for at least 1 year...
June 2018: Lancet Oncology
https://www.readbyqxmd.com/read/29725896/is-the-8th-edition-of-the-ajcc-tnm-staging-system-sufficiently-reasonable-for-all-patients-with-noncardia-gastric-cancer-a-12-549-patient-international-database-study
#17
Jun Lu, Zhi-Fang Zheng, Jian-Wei Xie, Jia-Bin Wang, Jian-Xian Lin, Qi-Yue Chen, Long-Long Cao, Mi Lin, Ru-Hong Tu, Chang-Ming Huang, Chao-Hui Zheng, Ping Li
BACKGROUND: The aim of this work is to compare the prognostic ability between the 7th and 8th editions of the American Joint Committee on Cancer (AJCC) tumor-node-metastasis (TNM) classification for gastric cancer (GC). METHODS: A total of 10,194 noncardia GC patients were identified from the Surveillance, Epidemiology, and End Results database from 1988 to 2008. Concordance index (C-index), bayesian information criterion (BIC), and time-dependent receiver operating characteristic (t-ROC) analyses were used...
July 2018: Annals of Surgical Oncology
https://www.readbyqxmd.com/read/29684240/external-laryngeal-nerve-landmarks-revisited
#18
Consuelo Ortega, Eva Maranillo, Steve McHanwell, Jose Sañudo, Teresa Vázquez-Osorio
BACKGROUND: Because external laryngeal nerve (ELN) iatrogenic damage is frequent during neck surgery, its precise localization has been highly recommended. This study analyzes the different surgical landmarks previously proposed and the anatomy of the collateral and terminal branches of the ELN. METHODS: The necks of 157 (77 men and 80 women) human adult embalmed cadavers were examined. The ELN origin, length, and relationship to different landmarks were recorded and results statistically compared with those previously reported...
April 23, 2018: Head & Neck
https://www.readbyqxmd.com/read/29672406/number-of-examined-lymph-nodes-and-nodal-status-assessment-in-distal-pancreatectomy-for-body-tail-ductal-adenocarcinoma
#19
Giuseppe Malleo, Laura Maggino, Cristina R Ferrone, Giovanni Marchegiani, Mari Mino-Kenudson, Paola Capelli, Borislav Rusev, Keith D Lillemoe, Claudio Bassi, Carlos Fernàndez-Del Castillo, Roberto Salvia
OBJECTIVE: First, to assess the impact of the number of examined lymph nodes (ELNs) on staging and survival after distal pancreatectomy (DP) for pancreatic adenocarcinoma (PDAC). Second, to identify the minimum number of ELNs (MNELNs) ensuring an accurate detection of nodal involvement. Third, to reappraise the role of lymph node (LN) parameters, including N-status and lymph node ratio (LNR). BACKGROUND: In contrast with pancreatoduodenectomy, information on LN staging and the MNELN required in DP is lacking...
April 18, 2018: Annals of Surgery
https://www.readbyqxmd.com/read/29614955/a-method-for-determining-haploid-and-triploid-genotypes-and-their-association-with-vascular-phenotypes-in-williams-syndrome-and-7q11-23-duplication-syndrome
#20
Michael D Gregory, Bhaskar Kolachana, Yin Yao, Tiffany Nash, Dwight Dickinson, Daniel P Eisenberg, Carolyn B Mervis, Karen F Berman
BACKGROUND: Williams syndrome ([WS], 7q11.23 hemideletion) and 7q11.23 duplication syndrome (Dup7) show contrasting syndromic symptoms. However, within each group there is considerable interindividual variability in the degree to which these phenotypes are expressed. Though software exists to identify areas of copy number variation (CNV) from commonly-available SNP-chip data, this software does not provide non-diploid genotypes in CNV regions. Here, we describe a method for identifying haploid and triploid genotypes in CNV regions, and then, as a proof-of-concept for applying this information to explain clinical variability, we test for genotype-phenotype associations...
April 4, 2018: BMC Medical Genetics
keyword
keyword
161229
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"